FDA Drug Application (021536) for LEVEMIR PENFILL by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number021536
Product Number004
FormINJECTABLE;SUBCUTANEOUS
Dosage300 UNITS/3ML (100 UNITS/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLEVEMIR PENFILL
Active IngredientINSULIN DETEMIR RECOMBINANT

Active IngredientCount
List of drugs with Active Ingredient INSULIN DETEMIR RECOMBINANT5


Back to FDA Applications sponsored by NOVO NORDISK INC